Clinical TrialsSearch results
Number of results: 972
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A randomized, participant and investigator-blinded, placebo-controlled, single ascending intravenous and single subcutaneous dose study to assess the safety, tolerability and pharmacokinetics of CMK389 in Japanese healthy participants
- Japanese healthy participants
- Yamada Hiroyuki
- 2022-01-21
Other
- Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2008-11-10
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01
Other
- A genotype directed dose-finding study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer.
- colorectal cancer/ gastric cancer
- Yakult Honsha Co.,Ltd
- 2006-11-01
Completed
- A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
- Schizophrenia
- Yabuuchi Kazuki
- 2021-04-05
Recruiting
- A novel technique of postoperative pain management for hip surgery
- femoral neck fracture, trochanteric fracture, osteoarthritis of hip, femoral head necrosis, and hip
- XIE JUN
- 2023-09-29
Completed
- A study in healthy men to test how well different doses of BI 1584862 are tolerated
- geographic atrophy (GA)
- Wu Haoyu
- 2023-11-10
Other
- A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV Non-small cell lung cancer
- West Japan Thoracic Oncology Group (WJTOG)
- 2005-09-04
Other
- Randomized controlled trial of mizoribine for progressive IgA nephropathy
- IgA nephropathy with moderate to severe histological alterations
- West Japan Study Group for Therapy of IgA Nephropathy
- 2007-02-05
Other
- To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC
- unresectable stage III NSCLC
- West Japan Oncology Group
- 2005-08-29